Alcon, Inc. Medical Equipment Company Share Analysis
| Publication Date | October 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 100 |
| ISBN Number | not applicable |
| Product Code | GMD06025 |
Summary
This report is an essential source for data, analysis and strategic insight into Alcon, Inc. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines companys business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the companys strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.
Scope
- Revenues for the markets and sub-sectors Alcon, Inc operates in by country and region.
- Detailed breakdowns of revenues and market share benchmarked against competitors.
- Profiles of the pipeline of products that the company is developing.
- Critical analysis of the companys strengths, weaknesses opportunities and threats and positioning on the value chain.
- Provides summary analysis of key revenue lines and strategy.
- Details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
- Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.
Reasons to buy
- A single source to fulfill all of your business and competitor intelligence needs
- Research your competitors business structure, strategy and prospects.
- Counter your competitors strengths and target their weaknesses.
- Identify your competitors key revenue streams by market and geography.
- Identify and assess potential corporate and investment opportunities
- Support sales activities by understanding your customers businesses better.
- Identify potential competitor products before they reach market.
- Qualify prospective partners and suppliers.
Content
- 1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of the Markets/Categories Covered
- 3.1 Ophthalmic Devices
- 3.1.1 Cataract Surgery
- 3.1.2 Refractive Surgery
- 3.1 Ophthalmic Devices
- 4 Company Snapshot
- 4.1 Key Information
- 4.2 Company Overview
- 4.3 Financial Performance
- 4.4 SWOT Snapshot
- 5 Business Description
- 5.1 Business Overview
- 5.2 Alcon International
- 5.2.1 Overview
- 5.2.2 Financials
- 5.2.3 Market View
- 5.3 Alcon United States
- 5.3.1 Overview
- 5.3.2 Financials
- 5.3.3 Market View
- 5.4 Major Products and Services
- 5.4.1 Overview
- 6 History
- 7 Business Strategy
- 7.1 Mission Statement
- 7.2 Strategy
- 7.3 Corporate Social Responsibility
- 7.3.1 Overview
- 7.3.2 Specific CSR Initiatives
- 8 Value Chain Analysis
- 8.1 Manufacturing
- 8.1.1 In House Manufacturing
- 8.1.2 Outsourcing
- 8.2 Product Development
- 8.2.1 Regulatory Approvals
- 8.2.2 Clinical Trials
- 8.2.3 Research and Development
- 8.3 Sales and Marketing
- 8.3.1 Partnerships and Alliances
- 8.3.2 Licensing Agreements
- 8.1 Manufacturing
- 9 SWOT Analysis
- 9.1 Overview
- 9.2 Alcon, Inc. Strengths
- 9.2.1 Financial Strength and Geographic Diversity
- 9.2.2 Market Presence
- 9.2.3 Extensive research and development
- 9.3 Alcon, Inc. Weaknesses
- 9.3.1 Product Termination
- 9.3.2 Lack of Manufacturing Facilities
- 9.4 Alcon, Inc. Opportunities
- 9.4.1 Agreements
- 9.4.2 Product Approvals
- 9.4.3 Aging U.S. Population
- 9.5 Alcon, Inc. Threats
- 9.5.1 Regulatory Process
- 9.5.2 Risk of patent expiration
- 9.5.3 Stringent reimbursement policies
- 10 Competitors
- 11 Alcon, Inc. Medical Equipment Market Share Analysis by Category
- 11.1 Alcon, Inc., Ophthalmic Devices by Category, Global, Market Share (2007)
- 11.2 Alcon, Inc., Ophthalmic Devices by Category, APAC, Market Share (2007)
- 11.3 Alcon, Inc., Ophthalmic Devices by Category, Europe, Market Share (2007)
- 11.4 Alcon, Inc., Ophthalmic Devices by Category, MEA, Market Share (2007)
- 11.5 Alcon, Inc., Ophthalmic Devices by Category, North America, Market Share (2007)
- 11.6 Alcon, Inc., Ophthalmic Devices by Category, SCA, Market Share (2007)
- 12 Revenue Analysis
- 12.1 Revenue by Segment
- 12.2 Revenue by Geography
- 13 Financial and Operational Review
- 13.1 Financial Statements
- 13.2 Financial Ratios
- 14 Share Holding Structure
- 15 Key Employees
- 16 Key Employee Biographies
- 17 Company Statement
- 18 Locations And Subsidiaries
- 18.1 Head Office
- 18.2 Other Locations & Subsidiaries
- 19 Financial Deals Landscape
- 19.1 Asset Purchase
- 19.1.1 Alcon Cusi Sells Its Lens Manufacturing Facility to AMO Manufacturing Spain
- 19.2 Acquisition
- 19.2.1 Novartis Acquires Minority Stake in Alcon from Nestle
- 19.2.2 Alcon Acquires WaveLight
- 19.3 IPO
- 19.3.1 Alcon Completes Initial Public Offering
- 19.3.2 Advanced Medical Optics and Alcon enter into Cross-Licensing Agreement
- 19.3.3 Eli Lilly and Company and Alcon Enter Into a Co-Promotion Agreement
- 19.3.4 Alcon Signs an Agreement with Amgen
- 19.1 Asset Purchase
- 20 Recent Developments
- 20.1 Strategy and Business Planning
- 20.1.1 Apr 13, 2008: Alcon to Build New Pharmaceutical Manufacturing Plant In Singapore
- 20.1.2 Sep 10, 2007: Alcon to Expand Swiss Operations
- 20.2 Financial Announcements
- 20.2.1 Jul 23, 2008: Alcon Reports 2Q 2008 Results
- 20.2.2 Jun 20, 2008: Alcon Laboratories Spends $0.24 Million on Lobbying In Q1 2008
- 20.2.3 Jun 17, 2008: Alcon to Declare Q2 2008 Results
- 20.2.4 May 06, 2008: Alcon Approves Dividend
- 20.2.5 Apr 23, 2008: Alcon Declares Q1 2008 Results
- 20.2.6 Mar 28, 2008: Alcon to Declare Q1 2008 Results
- 20.2.7 Feb 06, 2008: Alcon Declares Q4 2007 Results
- 20.2.8 Oct 24, 2007: Alcon Declares Q3 2007 Results
- 20.2.9 Jul 25, 2007: Alcon Declares Q2 2007 Results
- 20.2.10 May 09, 2007: Alcon Approves Dividend
- 20.2.11 Apr 25, 2007: Alcon's Q1 Global Sales Up By 14.3%
- 20.2.12 Mar 26, 2007: Alcon Announces Q1 2007 Financial Release Date
- 20.2.13 Feb 07, 2007: Alcon Declares Q4 2006 Results
- 20.2.14 Oct 23, 2006: Alcon's Q3 Global Sales Up By 12.4%
- 20.2.15 Sep 18, 2006: Alcon Announces Q3 2006 Financial Release Date
- 20.2.16 Sep 08, 2006: Alcon Approves Repurchase of 5 Million Additional Shares
- 20.2.17 Jul 24, 2006: Alcon's Q2 Global Sales Up 11.8% to $1,310.8 Million
- 20.2.18 Jun 19, 2006: Alcon Announces Q2 2006 Financial Release Date
- 20.2.19 May 02, 2006: Alcon Approves Dividend
- 20.3 Other Significant Developments
- 20.3.1 May 06, 2008: Alcon Announces Board Changes
- 20.3.2 Mar 10, 2008: Alcon Announces Management Changes
- 20.3.3 Sep 10, 2007: Alcon Senior Vice President To Retire
- 20.3.4 Jul 16, 2007: Alcon Appoints New CFO
- 20.3.5 Jun 26, 2007: Bausch & Lomb Files Suit against Alcon
- 20.3.6 Jun 26, 2007: Alcon CFO to Leave
- 20.3.7 May 09, 2007: Alcon Elects Board Members
- 20.3.8 Jul 10, 2006: AMO Announces Patent Infringement Settlement with Alcon
- 20.3.9 May 02, 2006: Alcon Elects Board Members
- 20.1 Strategy and Business Planning
- 21 Alcon, Inc. Pipeline Products
- 21.1 AcrySof ReSTOR IOL +3.0 Add
- 21.1.1 Product Overview
- 21.1.2 Product Description
- 21.1.3 Product Status
- 21.2 AcrySof Low Power ReSTOR lens
- 21.2.1 Product Overview
- 21.2.2 Product Description
- 21.2.3 Product Status
- 21.3 AcrySof thin-profile IOL
- 21.3.1 Product Overview
- 21.3.2 Product Description
- 21.3.3 Product Status
- 21.4 AcrySof ReSTOR Toric IOL
- 21.4.1 Product Overview
- 21.4.2 Product Description
- 21.4.3 Product Status
- 21.5 AcrySof Angle-supported Phakic Lens
- 21.5.1 Product Overview
- 21.5.2 Product Description
- 21.5.3 Product Status
- 21.5.4 Clinical Trials
- 21.6 New CONSTELLATION Vitreoretinal System
- 21.6.1 Product Overview
- 21.6.2 Product Description
- 21.6.3 Product Status
- 21.1 AcrySof ReSTOR IOL +3.0 Add
- 22 Appendix
- 22.1 Global Markets Direct Research Methodology
- 22.2 Coverage
- 22.3 Secondary Research
- 22.4 Primary Research
- 22.5 Models
- 22.6 Forecasts
- 22.7 Expert Panels
- 22.8 Market Revenue Chapters
- 22.8.1 Abbreviations
- 22.8.2 Currency Conversions
- 22.9 About Global Markets Direct
- 22.10 Contact Us
- 22.11 Disclaimer
- 1 List of Tables
- Table 1: Alcon, Inc., Key Facts, 2007
- Table 2: Alcon, Inc., SWOT Analysis , 2007
- Table 3: Alcon, Inc. Cataract Surgery by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 4: Alcon, Inc. Refractive Surgery by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 5: Alcon, Inc. Cataract Surgery by Geography, APAC, Revenue ($ mn) and Market Share (%), 2007
- Table 6: Alcon, Inc. Refractive Surgery by Geography, APAC, Revenue ($ mn) and Market Share (%), 2007
- Table 7: Alcon, Inc. Cataract Surgery by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 8: Alcon, Inc. Refractive Surgery by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 9: Alcon, Inc. Cataract Surgery by Geography, MEA, Revenue ($ mn) and Market Share (%), 2007
- Table 10: Alcon, Inc. Refractive Surgery by Geography, MEA, Revenue ($ mn) and Market Share (%), 2007
- Table 11: Alcon, Inc. Cataract Surgery by Geography, North America, Revenue ($ mn) and Market Share (%), 2007
- Table 12: Alcon, Inc. Refractive Surgery by Geography, North America, Revenue ($ mn) and Market Share (%), 2007
- Table 13: Alcon, Inc. Cataract Surgery by Geography, SCA, Revenue ($ mn) and Market Share (%), 2007
- Table 14: Alcon, Inc. Refractive Surgery by Geography, SCA, Revenue ($ mn) and Market Share (%), 2007
- Table 15: Alcon, Inc., Revenue by Segment, USD Million, 2003-2007
- Table 16: Alcon, Inc., Revenue by Geography, USD Million, 2003-2007
- Table 17: Alcon, Inc., Financial Statements, USD Million, 2003-2007
- Table 18: Alcon, Inc., Financial Ratios, USD Million, 2003-2007
- Table 19: Alcon, Inc., Share Holding Structure
- Table 20: Alcon, Inc., Key Employees, 2007
- Table 21: Alcon, Inc., Other Locations
- Table 22: Abbreviations used in the Market Revenue Chapters
- Table 23: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: Alcon, Inc., Value Chain Analysis
- Figure 2: Alcon, Inc. Ophthalmic Devices by Category, Global, Share of Market (%), 2007
- Figure 3: Alcon, Inc. Ophthalmic Devices by Category, Global, Share of Market (%), 2007
- Figure 4: Alcon, Inc. Ophthalmic Devices by Category, APAC, Share of Market (%), 2007
- Figure 5: Alcon, Inc. Ophthalmic Devices by Category, APAC, Share of Market (%), 2007
- Figure 6: Alcon, Inc. Ophthalmic Devices by Category, Europe, Share of Market (%), 2007
- Figure 7: Alcon, Inc. Refractive Surgery by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Figure 8: Alcon, Inc. Ophthalmic Devices by Category, North America, Share of Market (%), 2006
- Figure 9: Alcon, Inc. Refractive Surgery by Geography, North America, Revenue ($ mn) and Market Share (%), 2007
- Figure 10: Alcon, Inc. Ophthalmic Devices by Category, SCA, Share of Market (%), 2006
- Figure 11: Alcon, Inc. Refractive Surgery by Geography, SCA, Revenue ($ mn) and Market Share (%), 2007
- Figure 12: Global Markets Direct Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 24 to 48 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















